Results 261 to 270 of about 548,432 (354)
Selenium‐Based Nanoplatforms: An Emerging Theranostic Paradigm for Gynecological Cancers
This reivew summarizes Selenium as a multifunctional anticancer regulator in gynecological cancers. It reduces tumor risk, enhances therapeutic efficacy, and reduces treatment toxicity. Selenium also overcomes chemoraditherapy resistance, improving overall treatment outcomes. ABSTRACT Gynecological cancers present significant therapeutic challenges due
Hejing Liu +9 more
wiley +1 more source
Salidroside ameliorates diabetic amyotrophy by targeting Caspase-3 to inhibit apoptosis. [PDF]
Wang H +4 more
europepmc +1 more source
Effects of mesenchymal stem cells on ovarian sirtuin 1 and caspase-3 in premature ovarian insufficiency mice [PDF]
Yulan He +11 more
openalex +1 more source
A novel resistance mechanism is mediated through phagocytosis of cancer cells by AR+ TAMs. This process, dependent on ANXA2, enables macrophages to acquire AR protein from engulfed tumor cells. The internalized AR translocates into the macrophage nucleus, where it binds directly to the IL‐6 promoter, augmenting IL‐6 transcription and secretion ...
Yong Luo +13 more
wiley +1 more source
Xanthohumol Triggers Pyroptotic in Prostate Cancer Cells via the Caspase-3/GSDME Signaling Pathway. [PDF]
Sun J +6 more
europepmc +1 more source
ABSTRACT Tumor immune escape is a major barrier to durable cancer immunotherapy, as advanced malignancies create a tumor microenvironment (TME) that preferentially exhausts and disables T cell responses. While most approved cell therapies are T cell‐based, this limitation motivates the exploration of an alternative effector cell platform.
Tereza Kochs +4 more
wiley +1 more source
Non-genetic inactivation of caspase-3 and P53 increases cancer cell fitness by PDIA4 redistribution. [PDF]
Twito G +10 more
europepmc +1 more source

